Active, Not Recruiting
A Study of Gilteritinib, Venetoclax and Azacitidine as a Combined Treatment for People Newly Diagnosed With Acute Myeloid Leukemia
NCT05520567
- Conditions
- Acute Myeloid Leukemia (AML), FLT3-mutated Acute Myeloid Leukemia, Hematologic Diseases, +6 more
- Locations
-
- City of Hope Nat'l Medical Center Duarte, California, United States
- Univ. of California - Irvine Irvine, California, United States
- UCLA Medical Center Los Angeles, California, United States
- Sarah Cannon Research Institute Denver, Colorado, United States